Moderna's stock is at an all-time high after early but promising results for its coronavirus vaccine. Here's why top banks like Goldman Sachs say it can surge another 20%. (MRNA)

7:21am PDT - July 15th, 2020    moderna stock - Business Insider

• Moderna's stock on Wednesday rose to a record high, valuing the company at more than $30 billion.
• On Tuesday, federal researchers published the first human data from Moderna's coronavirus vaccine program. The early results were promising, sh…